Industry Analysis & Industry Trends
Thin film drug manufacturers have experienced rapid revenue growth over the past five years, and this trend is expected to continue over the five years to 2019 as the patent cliff enables more generic drugs to enter the market. Further, over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments.... purchase to read more
Industry Report - Industry Investment Chapter
The Thin Film Drug Manufacturing industry exhibits a high level of capital intensity. In 2014, for every dollar spent on labor, the industry incurs about $0.36 in capital expenditures. Overall, the industry is capital intensive, due to the need to invest in manufacturing equipment, such as solvent casting and hot melt extrusion (see Technology & Systems). Furthermore, the industry has capital costs related to securing active pharmaceutical ingredients (APIs), and chemicals, surfactants as well as flavor ingredients. To mitigate high purchase costs, many companies have partnered with healthcare technology firms that specialize in developing water soluble strips, thereby keeping purchase costs relatively lower.
Comparatively, wages account for an estimated 13.8% of industry revenue... purchase to read more